Waypoint Acquisition
Guideway Care Acquires Waypoint Healthcare Solutions to Expand Enterprise Patient Activation Intelligence Solution


KANSAS CITY, Mo., and BIRMINGHAM, Ala., March 3, 2026 — Guideway Care, Inc. today announced it has completed the acquisition and integration of Waypoint Healthcare Solutions, LLC to extend Guideway’s Enterprise Evidence-Based Patient Activation Intelligence solution and accelerate the creation of a unified architecture for governing execution across the pre- and post-encounter layers of healthcare. Waypoint’s entire team, including founders Lisa McDermott and David Bradshaw, has joined the Guideway family.
From its origins in providing journey management assistance to patients and members in disease-specific interactions, Guideway has become the national leader in using Evidence-Based Patient Activation to deliver Enterprise Activation Intelligence, delivering one comprehensive solution spanning methods, people, process, technology, behavioral science, and platform across the full care journey.
“Healthcare payers and providers have invested heavily in electronic health records, digital front doors, nurse triage platforms, population health analytics, and enterprise AI,” said Craig Parker, Chief Executive Officer of Guideway Care. “Yet enterprise performance still depends on whether patients or members complete the right actions at the right time.
The addition of Waypoint’s team and technology gives us additional AI and virtual agent tools to expand our reach and improve our efficiency while allowing us to tailor every interaction to each patient’s preferred activation pathway.
Together, we now deliver a unified and integrated Activation Intelligence solution that connects payer and provider strategy directly to measurable completion across access, referral management, care transitions, chronic condition management, and enterprise growth,” Parker added.
“For years, the biggest barrier to delivering measurable clinical and financial outcomes has not been effort or investment — it has been effective execution,” said David Bradshaw, Chief Executive Officer of Waypoint. “Healthcare has no shortage of strategy or technology. What it lacks are proven solutions that ensure the next right step is completed at scale. We have been working with Guideway to deliver that transformation for some time and the combination allows us to deliver more results, to more clients, at a faster pace.”
Hospitals and health systems are under sustained pressure to expand service lines, reduce referral leakage, improve nurse triage execution, convert find-a-physician demand into scheduled care, manage chronic populations, reduce avoidable utilization and unnecessary emergency department (ER) over-utilization, close preventive care gaps under value-based contracts, and strengthen performance under risk-based arrangements.
Risk-bearing entities, including payers and ACOs, must reduce medical cost trend, improve member adherence, close quality gaps, improve risk adjustment accuracy, manage avoidable utilization, address social determinants of health barriers, and ensure measurable completion across value-based populations.
Despite significant investments in digital infrastructure and enterprise healthcare AI, structural breakdowns persist in the space between clinical recommendation and completed patient action.
Across the industry, recurring gaps remain:
These are not engagement failures. They are activation failures occurring in the non-clinical layer — before encounters, between encounters, and after encounters — where enterprise performance is ultimately determined.
Over the past decade, healthcare has invested heavily in outreach programs, physician incentives, digital engagement platforms, and social determinants of health screening initiatives. Yet identifying barriers has not consistently translated into resolving them. Screening for SDoH, documenting needs, and layering technology onto workflows have not ensured that clinical instructions are completed. Execution — not identification — remains the missing discipline.
With the addition of Waypoint, Guideway Care now delivers a unified Activation Intelligence solution governing measurable Activation Objectives across the enterprise.
Guideway Care serves hospitals and health systems seeking enterprise-level improvements in referral closure, capacity expansion, access conversion, readmission reduction, HCAHPS improvement, chronic care management programs, and service line growth.
Guideway Care serves risk-bearing entities including ACOs and payers seeking measurable improvements in medical loss ratios, adherence, avoidable utilization reduction, and value-based contract performance.
Guideway Care supports strategic specialty programs seeking new procedures, retention, and measurable volume growth through governed activation infrastructure.
Across these segments, Activation Intelligence governs the non-encounter execution layer that determines material enterprise results.
Guideway Care is the Enterprise Evidence-Based Patient Activation company, delivering a comprehensive Activation Intelligence solution that transforms healthcare journeys from a Maze of Care to Amazing Care®. The Guideway GPS solution provides tested, governed, and structured behavioral execution for every patient or member interaction, including nurse triage service requests, find-a-physician conversion, referral management, readmission reduction, preventive care acceleration, chronic care management, care transitions, digital front door optimization, population health performance, avoidable utilization reduction, emergency department over-utilization reduction, service line growth, HCAHPS improvement, patient loyalty, and enterprise financial performance.
Activation Intelligence aligns health system strategy with measurable Activation Objectives and ensures that clinical instruction becomes completed action across the full care continuum. Rather than measuring engagement activity or layering technology onto workflows, Guideway Care achieves improved patient action — the unit of enterprise value.
The solution integrates structured patient activation science, proprietary non-clinical data, longitudinal barrier intelligence, human activation specialists, and AI activation agents into one unified execution system. Artificial intelligence operates as an amplification layer within this governed activation discipline, enabling precision, scalability, and real-time orchestration at enterprise scale.
The healthcare industry used clinical science and outcomes evidence to industrialize Evidence-Based Medicine. Guideway Care has now engineered a complete Evidence-Based Patient Activation solution as a complement to create value across the entire healthcare spectrum.
###

The addition of Waypoint’s team and technology gives us additional AI and virtual agent tools to expand our reach and improve our efficiency while allowing us to tailor every interaction to each patient’s preferred activation pathway. Together, we now deliver a unified and integrated Activation Intelligence solution that connects payer and provider strategy directly to measurable completion across access, referral management, care transitions, chronic condition management, and enterprise growth.
Guideway Care acquired and integrated Waypoint Healthcare Solutions to extend its Enterprise Evidence-Based Patient Activation Intelligence solution and accelerate the creation of a unified architecture for governing execution across the pre- and post-encounter layers of healthcare. The announcement positions the acquisition as a way to expand Guideway’s AI and virtual agent capabilities while strengthening its ability to connect payer and provider strategy to measurable completion across access, referral management, care transitions, chronic condition management, and enterprise growth.
The acquisition adds Waypoint’s team and technology to Guideway Care’s existing Activation Intelligence solution. According to Guideway CEO Craig Parker, Waypoint brings additional AI and virtual agent tools that can expand Guideway’s reach, improve efficiency, and support more tailored interactions based on each patient’s preferred activation pathway. Waypoint’s entire team, including founders Lisa McDermott and David Bradshaw, joined Guideway Care as part of the acquisition and integration.
The Waypoint acquisition supports Guideway Care’s Enterprise Activation Intelligence strategy by expanding the infrastructure used to govern measurable Activation Objectives across the enterprise. The announcement describes Activation Intelligence as a unified solution that combines structured activation science, proprietary non-clinical data, activation-oriented voice capability, enterprise workflow orchestration, human Activation Specialists, and AI activation agents into one governed ecosystem. The acquisition helps Guideway expand that system across more workflows and patient/member interaction points.
Guideway Care identifies recurring execution gaps between clinical recommendation and completed patient action. These include referrals that are generated but not closed inside the network, post-discharge follow-up that is recommended but not completed within safe windows, diagnostic findings that decay between encounters, preventive screenings and chronic monitoring that lapse over time, digital access demand that does not convert into scheduled visits, and avoidable emergency department utilization that persists when patients are not activated to the most appropriate site of care.
Guideway Care describes these gaps as activation failures because the problem is not simply whether patients receive outreach, information, or reminders. The deeper issue is whether patients and members complete the right action at the right time. The announcement states that these failures often occur in the non-clinical layer before encounters, between encounters, and after encounters, where enterprise performance is ultimately determined. Guideway’s position is that execution, not identification alone, is the missing discipline.
Guideway Care describes human Activation Specialists and AI activation agents as complementary parts of one seamless activation infrastructure. Human specialists provide relational continuity, contextual judgment, and empathy. AI activation agents provide real-time detection, pattern recognition, and scalable orchestration. Together, they support activation across complex healthcare workflows where patients and members may need timely outreach, barrier resolution, guidance, escalation, or reinforcement to complete the next right step.
Guideway Care’s expanded Activation Intelligence solution supports workflows across digital front door conversion, nurse triage routing, referral management, diagnostic follow-through, care transitions, chronic condition management programs, gap closure, preventive care acceleration, and enterprise growth initiatives. The announcement also connects Guideway’s solution to readmission reduction, population health performance, avoidable utilization reduction, emergency department over-utilization reduction, service line growth, HCAHPS improvement, patient loyalty, and enterprise financial performance.
For hospitals and health systems, the acquisition supports Guideway Care’s ability to address enterprise-level challenges such as referral closure, capacity expansion, access conversion, readmission reduction, HCAHPS improvement, chronic care management programs, and service line growth. The announcement also notes that hospitals and health systems are under pressure to expand service lines, reduce referral leakage, improve nurse triage execution, convert find-a-physician demand into scheduled care, manage chronic populations, and reduce avoidable emergency department over-utilization.
For risk-bearing entities, including payers and ACOs, the acquisition supports Guideway Care’s focus on measurable improvements in medical loss ratios, adherence, avoidable utilization reduction, and value-based contract performance. The announcement states that risk-bearing organizations must reduce medical cost trend, improve member adherence, close quality gaps, improve risk adjustment accuracy, manage avoidable utilization, address social determinants of health barriers, and ensure measurable completion across value-based populations.
This acquisition reinforces Guideway Care’s positioning as the Enterprise Evidence-Based Patient Activation company. The announcement frames Guideway’s solution as a comprehensive Activation Intelligence system that transforms healthcare journeys from a “Maze of Care” to “Amazing Care®” by aligning health system strategy with measurable Activation Objectives. Rather than measuring engagement activity alone, Guideway’s model is focused on helping clinical instruction become completed patient or member action across the full care continuum.
We use cookies and similar technologies to improve your experience on our website. Read our Privacy Policy.